- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury ; day:23 ; month:8 ; year:2023 ; pages:1-21
Neurotherapeutics ; (23.8.2023), 1-21
- Creator
-
Lindblad, Caroline
Rostami, Elham
Helmy, Adel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13311-023-01421-0
- URN
-
urn:nbn:de:101:1-2023110609403211408988
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lindblad, Caroline
- Rostami, Elham
- Helmy, Adel
- SpringerLink (Online service)
Other Objects (12)
Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
Production of interleukin-1 receptor antagonist by human articular chondrocytes
Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist
Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist
Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury
Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer
Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer
Neuroprotective Effects of CXCR2 Antagonist SB332235 on Traumatic Brain Injury Through Suppressing NLRP3 Inflammasome
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
The role of Interleukin-1-Receptor-Antagonist in bladder cancer cell migration and invasion
Inhibition of inflammatory vasculopathic processes by interleukin-1 receptor antagonist, transduced endothelial progenitor cells
Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
Production of interleukin-1 receptor antagonist by human articular chondrocytes
Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist
Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist
Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury
Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer
Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer
Neuroprotective Effects of CXCR2 Antagonist SB332235 on Traumatic Brain Injury Through Suppressing NLRP3 Inflammasome
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
The role of Interleukin-1-Receptor-Antagonist in bladder cancer cell migration and invasion
Inhibition of inflammatory vasculopathic processes by interleukin-1 receptor antagonist, transduced endothelial progenitor cells
Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
Production of interleukin-1 receptor antagonist by human articular chondrocytes
Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist
Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist
Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury
Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer
Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer
Neuroprotective Effects of CXCR2 Antagonist SB332235 on Traumatic Brain Injury Through Suppressing NLRP3 Inflammasome
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
The role of Interleukin-1-Receptor-Antagonist in bladder cancer cell migration and invasion
Inhibition of inflammatory vasculopathic processes by interleukin-1 receptor antagonist, transduced endothelial progenitor cells